🔵 Responding to today’s launch of the UK’s next five-year national action plan for antimicrobial resistance (AMR) 2024-2029, Dr Beverley Isherwood and Dr Clive Mason, PACE Programme Directors, said: 💬 “This announcement shines a light on the urgent needs around AMR. PACE was delighted to contribute to this policy paper, and we’re pleased to see the government’s commitment to optimising antimicrobials, overcoming barriers and investing in innovation. We are dedicated to funding and supporting the innovative scientific research being conducted globally to develop diagnostics, antimicrobials and alternative therapies which meet UK and global needs. The ability to sustain and grow our capabilities and skills to address AMR is critical. PACE will continue to support this vision.” ▶ Read more about PACE in Theme 3 – Investing in innovation, supply and access in section ‘Commitment 6.3 – Overcoming market barriers’. ▶ This five-year national action plan supports the UK 20-year vision for antimicrobial resistance. (🔗 https://lnkd.in/gDDPWf4g)
Today we have launched a new plan to tackle antimicrobial resistance (AMR). This national action plan commits the UK to: 🔵 reduce use of antimicrobials 🔵 strengthen surveillance of drug resistant infections before they emerge 🔵 incentivise industry to develop the next generation of treatments See our plan on Confronting Antimicrobial Resistance: https://lnkd.in/e9Xj6NxM #AMR #AntimicrobialResistance UK Research and Innovation, Department for Science, Innovation and Technology, UK Health Security Agency, Department for Environment, Food and Rural Affairs, Cabinet Office
